Abstract
By multiple criteria, inosiplex-a reputed stimulator of virus-sensitized lymphocytes-had no demonstrable therapeutic effects in a preliminary controlled study of patients with localized herpes zoster and cancer. Lymphocytes from the six drug-treated patients were no more responsive to varicella-zoster antigen and phytohemagglutinin than were lymphocytes from seven patients who received a placebo.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
-
Randomized Controlled Trial
MeSH terms
-
Child
-
Clinical Trials as Topic
-
Double-Blind Method
-
Herpes Zoster / complications
-
Herpes Zoster / drug therapy*
-
Humans
-
Immunity, Cellular / drug effects
-
Inosine / analogs & derivatives*
-
Inosine Pranobex / pharmacology
-
Inosine Pranobex / therapeutic use*
-
Neoplasms / complications
-
Placebos
Substances
-
Placebos
-
Inosine
-
Inosine Pranobex